A phase 1, single-dose study of fresolimumab, an anti-TGF-β antibody, in treatment-resistant primary focal segmental glomerulosclerosis (Q35669295)
Jump to navigation
Jump to search
scientific article published on 2 March 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A phase 1, single-dose study of fresolimumab, an anti-TGF-β antibody, in treatment-resistant primary focal segmental glomerulosclerosis |
scientific article published on 2 March 2011 |
Statements
1 reference
A phase 1, single-dose study of fresolimumab, an anti-TGF-β antibody, in treatment-resistant primary focal segmental glomerulosclerosis (English)
1 reference
Debbie S Gipson
1 reference
Fernando C Fervenza
1 reference
Peter Heering
1 reference
David R W Jayne
1 reference
Stefano Rota
1 reference
L Christian Rump
1 reference
Lorenz K Sellin
1 reference
Jeremy P W Heaton
1 reference
James B Streisand
1 reference
Marjie L Hard
1 reference
Steven R Ledbetter
1 reference
Flavio Vincenti
1 reference
2 March 2011
1 reference
1 reference
79
1 reference
11
1 reference
1236-1243
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference